Answer
Baricitinib should not be used during breastfeeding because a risk to newborns/infants cannot be excluded; a decision must be made whether to discontinue breastfeeding or therapy, considering the benefit of breastfeeding for the child and therapy for the woman.
Sources for this answer
- Baricitinib LillyEli Lilly and Company Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 7Document updated
Sources checked